163 related articles for article (PubMed ID: 3899816)
1. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats.
Rolston R; Ghiglione M; Bacarese-Hamilton AJ; Uttenthal LO; Bloom SR
Digestion; 1985; 32(2):124-7. PubMed ID: 3899816
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
[TBL] [Abstract][Full Text] [Related]
3. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats.
Dubrasquet M; Bataille D; Gespach C
Biosci Rep; 1982 Jun; 2(6):391-5. PubMed ID: 6125221
[No Abstract] [Full Text] [Related]
4. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion.
Jarrousse C; Audousset-Puech MP; Dubrasquet M; Niel H; Martinez J; Bataille D
FEBS Lett; 1985 Aug; 188(1):81-4. PubMed ID: 4018272
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
Creutzfeldt W; Fölsch UR; Elsenhans B; Ballmann M; Conlon JM
Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas.
Uttenthal LO; Ukponmwan OO; Wood SM; Ghiglione M; Ghatei MA; Trayner IM; Bloom SR
Diabet Med; 1986 Mar; 3(2):155-60. PubMed ID: 2951158
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man.
Schjoldager BT; Baldissera FG; Mortensen PE; Holst JJ; Christiansen J
Eur J Clin Invest; 1988 Oct; 18(5):499-503. PubMed ID: 3147901
[TBL] [Abstract][Full Text] [Related]
8. Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion.
Jarrousse C; Niel H; Audousset-Puech MP; Martinez J; Bataille D
Peptides; 1986; 7 Suppl 1():253-6. PubMed ID: 3748850
[TBL] [Abstract][Full Text] [Related]
9. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
Eissele R; Koop H; Arnold R
Z Gastroenterol; 1990 Mar; 28(3):129-31. PubMed ID: 1971469
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of gut hormone response to food by soluble fiber and alpha-glucosidase inhibition.
Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson DL; Misiewicz JJ; Alberti KG
Am J Gastroenterol; 1988 Apr; 83(4):393-7. PubMed ID: 2831707
[TBL] [Abstract][Full Text] [Related]
11. The gastric acid secretagogue gastrin-releasing peptide and the inhibitor oxyntomodulin do not exert their effect directly on the parietal cell in the rat.
Gehl J; Jeppesen JL; Poulsen SS; Holst JJ
Digestion; 1988; 40(3):144-51. PubMed ID: 3234620
[TBL] [Abstract][Full Text] [Related]
12. Exocrine and endocrine pancreatic function in rats treated with alpha-glucosidase inhibitor (acarbose).
Otsuki M; Sakamoto C; Ohki A; Okabayashi Y; Yuu H; Maeda M; Baba S
Metabolism; 1983 Aug; 32(8):846-50. PubMed ID: 6191180
[TBL] [Abstract][Full Text] [Related]
13. Effect of alpha-amylase and alpha-glucosidase inhibitors on caries incidence and plaque accumulation in rats.
Mörmann JE; Schmid R; Mühlemann HR
Caries Res; 1983; 17(4):353-6. PubMed ID: 6191863
[No Abstract] [Full Text] [Related]
14. Enteroglucagon release in disaccharide malabsorption induced by intestinal alpha-glucosidase inhibition.
Hayakawa T; Kondo T; Okumura N; Nagai K; Shibata T; Kitagawa M
Am J Gastroenterol; 1989 May; 84(5):523-6. PubMed ID: 2655436
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in man.
Veyrac M; Ribard D; Daures JP; Mion H; Lequellec A; Martinez J; Bataille D; Michel H
Scand J Gastroenterol; 1989 Dec; 24(10):1238-42. PubMed ID: 2690315
[TBL] [Abstract][Full Text] [Related]
16. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
[TBL] [Abstract][Full Text] [Related]
17. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
Kotler DP; Tierney AR; Kral JG; Bjorntorp P
Am J Clin Nutr; 1984 Aug; 40(2):270-6. PubMed ID: 6380264
[TBL] [Abstract][Full Text] [Related]
18. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
Digestion; 1992; 52(3-4):214-21. PubMed ID: 1459356
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic ethanol administration on the gastrointestinal hormones gastrin, enteroglucagon, pancreatic glucagon and peptide YY in the rat.
Simanowski UA; Hubalek K; Ghatei MA; Bloom SR; Polak JM; Seitz HK
Digestion; 1989; 42(3):167-73. PubMed ID: 2767348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
